- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04457492
Functional Electrical Stimulation for Facial Muscles
March 18, 2024 updated by: University Health Network, Toronto
Applying Functional Electrical Stimulation to Facial Muscles After Acute Paralysis
Partial or complete facial paralysis is the weakness of muscles of facial expression.
Facial paralysis causes physical, social and emotional problems.
Functional electrical stimulation (FES) for facial paralysis is a technique in which muscles are electrically stimulated, causing them to contract This study is designed to help patients with facial nerve weakness.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
1
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Alex Esemezie, BACYC
- Phone Number: 416-340-3082
- Email: alex.esemezie@uhn.ca
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 2C4
- University Health Network
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients experiencing unilateral facial nerve paralysis Brackmann 5/6 or 6/6.
Exclusion Criteria:
- History of epilepsy or seizures.
- Individuals with metal orthopedic implants in the mouth (e.g. plates or screws).
- Individuals suffering from fibromyalgia.
- Individuals currently receiving any form of transcranial brain stimulation (e.g. rTMS, ECT, or MST).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Acute Facial Nerve Injury with Intact Facial Nerve
40 sessions of FES (in a 14 week period) Assessments will be taken during the beginning, middle, and end of each study arm. |
Functional electrical stimulation (FES) for facial paralysis is a technique in which muscles are electrically stimulated.
|
Experimental: Facial Nerve Grafting After Surgical Excision
40 sessions of FES (in a 14 week period) Assessments will be taken during the beginning, middle, and end of each study arm. |
Functional electrical stimulation (FES) for facial paralysis is a technique in which muscles are electrically stimulated.
|
No Intervention: Standard of Care Group
No FES Assessments will be taken at the same intervals as the interventions group. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Lagophthalmos Over 14 weeks
Time Frame: Measured at week 0, 7 and 14
|
Change in ability to close eyelids, measured in mm
|
Measured at week 0, 7 and 14
|
Change in Elevation of Corner of Mouth Over 14 weeks
Time Frame: Measured at week 0, 7 and 14
|
Change in ability to raise corner of mouth, measured in mm
|
Measured at week 0, 7 and 14
|
Change House-Brackmann Scale Measurement Over 14 weeks
Time Frame: Measured at week 0, 7 and 14
|
The House-Brackmann facial nerve grading scale is a measure of facial nerve impairment.
The scale ranges from values 1 to 6, with larger values indicating greater facial nerve impairment.
|
Measured at week 0, 7 and 14
|
FaCE Questionnaire
Time Frame: Administered at week 0, 7 and 14
|
Patient-based instrument to measure both facial impairment and disability.
This will be used to identify patient's perceived change in facial impairment for the duration of the study period.
|
Administered at week 0, 7 and 14
|
Change in Facial Movements Over 14 weeks
Time Frame: Measured at week 0, 7 and 14
|
A video will be taken of the patient undergoing standard facial movements
|
Measured at week 0, 7 and 14
|
Study Interview
Time Frame: Administered at week 0, 7 and 14
|
A structured interview questionnaire administered by a study team member to identify any changes to the therapy that may be needed before further studies are conducted
|
Administered at week 0, 7 and 14
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Douglas Chepeha, MD, University Health Network, Toronto
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2021
Primary Completion (Actual)
March 16, 2023
Study Completion (Actual)
March 16, 2023
Study Registration Dates
First Submitted
June 8, 2020
First Submitted That Met QC Criteria
June 30, 2020
First Posted (Actual)
July 7, 2020
Study Record Updates
Last Update Posted (Actual)
March 20, 2024
Last Update Submitted That Met QC Criteria
March 18, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-5743
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Facial Nerve Paresis
-
University of UtahCompletedSynkinesis | Facial Asymmetry | Facial Nerve Injuries | Facial Paresis Associated With Facial Nerve Dysfunction
-
Assiut UniversityRecruiting
-
University of Missouri-ColumbiaCompleted
-
University Hospital, CaenTerminatedFacial ParesisFrance
-
Boston Children's HospitalNational Eye Institute (NEI); Howard Hughes Medical InstituteRecruitingOcular Motility Disorders | Facial Palsy | Synkinesis | Sixth Nerve Palsy | Mobius Syndrome | Congenital Fibrosis of Extraocular Muscles | Duane Retraction Syndrome | Duane Radial Ray Syndrome | Brown Syndrome | Marcus Gunn Syndrome | Strabismus Congenital | Horizontal Gaze Palsy | Horizontal Gaze Palsy With Progressive... and other conditionsUnited States
-
Assistance Publique - Hôpitaux de ParisRecruitingQuality of Life | Facial Palsy | Motor Recovery | Self-rehabilitationFrance
-
Samsung Medical CenterCompletedFacial Nerve Paresis | Parotid TumorsKorea, Republic of
-
Assiut UniversityNot yet recruiting
-
Mayo ClinicCompletedFacial Paralysis | Parotid NeoplasmsUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...UnknownInjury of Facial Nerve, Unspecified Side, Initial Encounter
Clinical Trials on Application of FES to the Face
-
Bartın UnıversityThe Scientific and Technological Research Council of TurkeyActive, not recruiting
-
University Hospital, Clermont-FerrandRecruitingBipolar Disorder Type I or II (According to DSM-5)France
-
Universidad Autonoma de Nuevo LeonCompleted
-
Ankara Yildirim Beyazıt UniversityNot yet recruiting
-
Aga Khan UniversityNot yet recruitingMalnutrition, Child | Malnutrition, InfantPakistan
-
E.BadiavasUnited States Department of DefenseCompleted
-
Lund UniversitySuspended
-
Hospices Civils de LyonCompleted
-
T.C. ORDU ÜNİVERSİTESİNot yet recruiting
-
Behavior Therapy Associates, LLPNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcoholismUnited States